BioStem Technologies, Inc. (BSEM) vs Metagenomi, Inc. Common Stock (MGX)

A side-by-side comparison of BioStem Technologies, Inc. and Metagenomi, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
BioStem Technologies, Inc. logo
BSEM
BioStem Technologies, Inc.
$45M
$2.63HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT
Metagenomi, Inc. Common Stock logo
MGX
Metagenomi, Inc. Common Stock
$40M
$1.07HealthcareDelayed quote: Oct 6, 2026, 10:51 AM EDT

Total return — BSEM vs MGX

growth of $100 · dividends reinvested · last 3y
BSEM -68.4% (-31.9%/yr)MGX -89.9% (-53.4%/yr)BSEM compounded faster over this window
0100200Start $10020252026$32$10
BSEM MGX

BSEM vs MGX: by the numbers

  • •BSEM is the larger company ($45M vs $40M market cap).
  • •Both run net losses; BSEM's is the smaller (-13.86% vs -689.20% net margin).

Metrics side by side

Valuation

MetricBSEMMGX
P/S ratioN/A2.97
P/B ratio1.620.36

Profitability

MetricBSEMMGX
Gross margin93.13%74.29%
Operating margin-1.45%-380.85%
Net margin-13.86%-689.20%
ROE-102.45%-83.03%
ROIC-80.92%-66.03%

Growth (annualized)

MetricBSEMMGX
Total return CAGR (5Y)15.72%N/A

Go deeper

Full BSEM analysisFull MGX analysisInteractive comparison tool

Dig into the metrics

BioStem Technologies ROEMetagenomi, Inc. Common Stock ROEBioStem Technologies operating marginMetagenomi, Inc. Common Stock operating marginBioStem Technologies revenue growthMetagenomi, Inc. Common Stock revenue growthBioStem Technologies free cash flowMetagenomi, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.